cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.drz87e
title: Occurrence Download

description: A dataset containing 286 species occurrences available in GBIF matching the query:
{
 "and" : [
 {
 "or" : [
 "BasisOfRecord is Observation",
 "BasisOfRecord is Machine Observation",
 "BasisOfRecord is Human Observation",
 "BasisOfRecord is Literature Occurrence"
 ]
 },
 {
 "or" : [
 "Country is Canada",
 "Country is United States of America"
 ]
 },
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "TaxonKey is Notropis lutipinnis (Jordan & Brayton, 1878)"
 ]
}

 The dataset includes 286 records from 2 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0296598-200613084148143/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.tdvvmn
title: Occurrence Download

description: A dataset containing 75 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Olsynium filifolium (Gaudich.) Goldblatt"
 ]
}

 The dataset includes 75 records from 18 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0301186-200613084148143/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.q35d5z
title: Occurrence Download

description: A dataset containing 212 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "TaxonKey is Homophyllia bowerbanki (Milne Edwards & Haime, 1857)"
 ]
}

 The dataset includes 212 records from 16 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0244812-200613084148143/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.dzdgeg
title: Occurrence Download

description: A dataset containing 72 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is Mexico",
 "Month is March",
 "Year 2016-2016",
 "TaxonKey is Phoenicopterus ruber Linnaeus, 1758"
 ]
}

 The dataset includes 72 records from 2 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0005864-180412121330197/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.5dzgvx
title: Occurrence Download

description: A dataset listing the 62965 species recorded in GBIF matching the query:
{
 "and" : [
 {
 "or" : [
 "BasisOfRecord is Observation",
 "BasisOfRecord is Machine Observation",
 "BasisOfRecord is Human Observation",
 "BasisOfRecord is Material sample",
 "BasisOfRecord is Literature Occurrence",
 "BasisOfRecord is Specimen",
 "BasisOfRecord is Living Specimen",
 "BasisOfRecord is Unknown evidence"
 ]
 },
 "Country is Austria",
 "Year 1000-2021"
 ]
}

 The dataset's 62965 records were derived from 864 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0044573-210914110416597/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.27014306
title: <i>SOD1</i> gene screening in ALS – frequency of mutations, patients’ attitudes to genetic information and transition to tofersen treatment in a multi-center program

description: <i>Objective</i>: To report the frequency of pathogenic <i>SOD1</i> gene variants in a screening program in amyotrophic lateral sclerosis (ALS), and the clinical practice of transition to an expanded access program (EAP) of tofersen treatment. <i>Methods</i>: From October 2021 to February 2024, at 11 ALS centers in Germany genetic testing for <i>SOD1</i>, <i>FUS</i>, <i>TARDBP,</i> and <i>C9orf72</i> was performed. Patients were offered to opt for notification either about all genetic variants or <i>SOD1</i> variants relevant for tofersen therapy. The transition to the EAP with tofersen was assessed. <i>Results</i>: 1935 patients were screened (94.7% sporadic ALS). 48.8% (<i>n</i> = 928) opted for notification of treatment-relevant information. Genetic variants were found as follows: <i>SOD1</i> (likely) pathogenic variants (class 4/5) 1.8% (<i>n</i> = 34), variants of unknown significance (class 3) 0.8% (<i>n </i>= 16), <i>FUS</i> (class 4/5) 0.9% (<i>n </i>= 17)<i>, TARDBP</i> (class 4/5) 1.3% (<i>n</i> = 25), <i>C9orf72</i> hexanucleotide repeat expansion 7.0% (<i>n </i>= 135). In <i>SOD1</i>-ALS (encompassing class 3–5 variants, <i>n </i>= 50), 68.0% (<i>n</i> = 34) reported a negative family history. 74.0% (<i>n </i>= 37) of <i>SOD1</i>-ALS patients – which represent 1.9% of all participants of the screening program – were transitioned to tofersen. Median duration from start of genetic testing to treatment was 94 days (57 to 295 days). Eight patients declined treatment whereas five individuals died before initiation of therapy. <i>Conclusion</i>: The finding of <i>SOD1</i> variants in patients with a negative family history underscores the need for a broad genetic screening in ALS. In <i>SOD1</i>-ALS, the treatment option with tofersen was mostly utilized. The wide range in the transition time to tofersen calls for a <i>SOD1</i>-ALS management program.
DOI: 10.6084/m9.figshare.27014306.v1
title: <i>SOD1</i> gene screening in ALS – frequency of mutations, patients’ attitudes to genetic information and transition to tofersen treatment in a multi-center program

description: <i>Objective</i>: To report the frequency of pathogenic <i>SOD1</i> gene variants in a screening program in amyotrophic lateral sclerosis (ALS), and the clinical practice of transition to an expanded access program (EAP) of tofersen treatment. <i>Methods</i>: From October 2021 to February 2024, at 11 ALS centers in Germany genetic testing for <i>SOD1</i>, <i>FUS</i>, <i>TARDBP,</i> and <i>C9orf72</i> was performed. Patients were offered to opt for notification either about all genetic variants or <i>SOD1</i> variants relevant for tofersen therapy. The transition to the EAP with tofersen was assessed. <i>Results</i>: 1935 patients were screened (94.7% sporadic ALS). 48.8% (<i>n</i> = 928) opted for notification of treatment-relevant information. Genetic variants were found as follows: <i>SOD1</i> (likely) pathogenic variants (class 4/5) 1.8% (<i>n</i> = 34), variants of unknown significance (class 3) 0.8% (<i>n </i>= 16), <i>FUS</i> (class 4/5) 0.9% (<i>n </i>= 17)<i>, TARDBP</i> (class 4/5) 1.3% (<i>n</i> = 25), <i>C9orf72</i> hexanucleotide repeat expansion 7.0% (<i>n </i>= 135). In <i>SOD1</i>-ALS (encompassing class 3–5 variants, <i>n </i>= 50), 68.0% (<i>n</i> = 34) reported a negative family history. 74.0% (<i>n </i>= 37) of <i>SOD1</i>-ALS patients – which represent 1.9% of all participants of the screening program – were transitioned to tofersen. Median duration from start of genetic testing to treatment was 94 days (57 to 295 days). Eight patients declined treatment whereas five individuals died before initiation of therapy. <i>Conclusion</i>: The finding of <i>SOD1</i> variants in patients with a negative family history underscores the need for a broad genetic screening in ALS. In <i>SOD1</i>-ALS, the treatment option with tofersen was mostly utilized. The wide range in the transition time to tofersen calls for a <i>SOD1</i>-ALS management program.
DOI: 10.6084/m9.figshare.27014398.v1
title: 新建 文本文档.txt

description: test
DOI: 10.6084/m9.figshare.27014398
title: 新建 文本文档.txt

description: test
DOI: 10.6084/m9.figshare.25712754
title: The Effect of Steroid Intervention before Vitrectomy for Rhegmatogenous Retinal Detachment Associated with Choroidal Detachment: A Meta-Analysis and Systematic Review

description: This meta-analysis discusses the effectiveness of steroid intervention before vitrectomy in patients with rhegmatogenous retinal detachment associated with choroidal detachment. We searched PubMed, MEDLINE, EMBASE, and the Cochrane Library for randomized controlled trials and observational studies published until August 2023. We included studies involving: patients with rhegmatogenous retinal detachment associated with choroidal detachment with proliferative vitreoretinopathy; an experimental group that was not administered steroids and a control group that was administered steroids; and assessment of visual acuity, retinal reattachment rate, and complications. The heterogeneity, publication bias, and sensitivity analysis were performed to ensure the statistical power and reliability of the analysis. Two randomized controlled trials and four case-control studies involving 490 eyes were included in the meta-analysis. There were no significant differences in the primary and final retinal reattachment rates after surgery between the steroid and non-steroid groups (primary retinal reattachment rate: odds ratio = 1.01, 95% confidence interval = 0.63–1.63, <i>p</i> = .41; final retinal reattachment rate: odds ratio = 0.82, 95% confidence interval = 0.43–1.59, <i>p</i> = .33). There was no statistically significant difference in postoperative visual acuity improvement between the two groups (odds ratio = 1.19, confidence interval = 0.63–2.25, <i>p</i> = .69). In addition, subgroup analyses of different types of steroids showed that systemic and local administration of steroids had similar results for retinal reattachment rate and visual acuity improvement. Patients with rhegmatogenous retinal detachment associated with choroidal detachment who did not receive preoperative steroids achieved the same effect as patients with rhegmatogenous retinal detachment associated with choroidal detachment who did receive preoperative steroids in terms of retinal reattachment rate and visual acuity. It is recommended that patients with rhegmatogenous retinal detachment associated with choroidal detachment undergo surgery as promptly as possible.
DOI: 10.6084/m9.figshare.25712754.v1
title: The Effect of Steroid Intervention before Vitrectomy for Rhegmatogenous Retinal Detachment Associated with Choroidal Detachment: A Meta-Analysis and Systematic Review

description: This meta-analysis discusses the effectiveness of steroid intervention before vitrectomy in patients with rhegmatogenous retinal detachment associated with choroidal detachment. We searched PubMed, MEDLINE, EMBASE, and the Cochrane Library for randomized controlled trials and observational studies published until August 2023. We included studies involving: patients with rhegmatogenous retinal detachment associated with choroidal detachment with proliferative vitreoretinopathy; an experimental group that was not administered steroids and a control group that was administered steroids; and assessment of visual acuity, retinal reattachment rate, and complications. The heterogeneity, publication bias, and sensitivity analysis were performed to ensure the statistical power and reliability of the analysis. Two randomized controlled trials and four case-control studies involving 490 eyes were included in the meta-analysis. There were no significant differences in the primary and final retinal reattachment rates after surgery between the steroid and non-steroid groups (primary retinal reattachment rate: odds ratio = 1.01, 95% confidence interval = 0.63–1.63, <i>p</i> = .41; final retinal reattachment rate: odds ratio = 0.82, 95% confidence interval = 0.43–1.59, <i>p</i> = .33). There was no statistically significant difference in postoperative visual acuity improvement between the two groups (odds ratio = 1.19, confidence interval = 0.63–2.25, <i>p</i> = .69). In addition, subgroup analyses of different types of steroids showed that systemic and local administration of steroids had similar results for retinal reattachment rate and visual acuity improvement. Patients with rhegmatogenous retinal detachment associated with choroidal detachment who did not receive preoperative steroids achieved the same effect as patients with rhegmatogenous retinal detachment associated with choroidal detachment who did receive preoperative steroids in terms of retinal reattachment rate and visual acuity. It is recommended that patients with rhegmatogenous retinal detachment associated with choroidal detachment undergo surgery as promptly as possible.
DOI: 10.26249/fk2/vagufz/rkrwzz
title: Fig3a.zip

description: :unav
DOI: 10.26249/fk2/vagufz/1mb2it
title: Fig5b.zip

description: :unav
DOI: 10.26249/fk2/vagufz/cfazsj
title: Fig5a.zip

description: :unav
DOI: 10.26249/fk2/vagufz/gtu2jo
title: start_B_MC.csv

description: :unav
DOI: 10.26249/fk2/vagufz/peit7x
title: Fig3b.zip

description: :unav
DOI: 10.26249/fk2/vagufz/wrctdk
title: Fig4a_and_Fig4b.zip

description: :unav
DOI: 10.26249/fk2/vagufz/aulk34
title: readme.txt

description: :unav
DOI: 10.26249/fk2/vagufz/givczj
title: start_F_Jumps.csv

description: :unav
DOI: 10.26249/fk2/vagufz/ig1qpm
title: start_F_SW.csv

description: :unav
DOI: 10.26249/fk2/vagufz/ormmnl
title: readme.txt

description: :unav
DOI: 10.26249/fk2/vagufz/osprsb
title: start_F_MC.csv

description: :unav
DOI: 10.26249/fk2/vagufz/zwoc26
title: start_B_SW.csv

description: :unav
DOI: 10.26249/fk2/vagufz/ejxy59
title: start_B_trajectories_part_010.csv

description: :unav
DOI: 10.26249/fk2/vagufz/f4el75
title: readme.txt

description: :unav
DOI: 10.26249/fk2/vagufz/h3ia0n
title: start_B_Jumps.csv

description: :unav
DOI: 10.26249/fk2/vagufz/nl1flp
title: start_B_trajectories_part_019.csv

description: :unav
DOI: 10.26249/fk2/vagufz/ub6qlj
title: start_B_trajectories_part_004.csv

description: :unav
DOI: 10.26249/fk2/vagufz/ugudo9
title: start_B_trajectories_part_015.csv

description: :unav
DOI: 10.26249/fk2/vagufz/eqbwme
title: start_B_trajectories_part_018.csv

description: :unav
DOI: 10.26249/fk2/vagufz/ny2t5a
title: start_B_trajectories_part_008.csv

description: :unav
DOI: 10.26249/fk2/vagufz/p8o4z8
title: start_B_trajectories_part_007.csv

description: :unav
DOI: 10.26249/fk2/vagufz/u8tcyp
title: start_B_trajectories_part_005.csv

description: :unav
DOI: 10.26249/fk2/vagufz/zmux4w
title: start_B_trajectories_part_000.csv

description: :unav
DOI: 10.26249/fk2/vagufz/zuuxrl
title: start_B_trajectories_part_017.csv

description: :unav
DOI: 10.26249/fk2/vagufz/bed9hy
title: start_B_trajectories_part_002.csv

description: :unav
DOI: 10.26249/fk2/vagufz/g34vgo
title: start_B_trajectories_part_014.csv

description: :unav
DOI: 10.26249/fk2/vagufz/kuxrxa
title: start_B_trajectories_part_012.csv

description: :unav
DOI: 10.26249/fk2/vagufz/rqz0ko
title: start_B_trajectories_part_006.csv

description: :unav
DOI: 10.26249/fk2/vagufz/wjflsz
title: _start_B_log.dat

description: :unav
DOI: 10.26249/fk2/vagufz/2bp3ib
title: start_B_trajectories_part_003.csv

description: :unav
DOI: 10.26249/fk2/vagufz/bjncy7
title: start_B_trajectories_part_009.csv

description: :unav
DOI: 10.26249/fk2/vagufz/edzbke
title: start_B_trajectories_part_001.csv

description: :unav
DOI: 10.26249/fk2/vagufz/l01m9l
title: start_B_trajectories_part_020.csv

description: :unav
DOI: 10.26249/fk2/vagufz/oexcqe
title: start_B_trajectories_part_011.csv

description: :unav
DOI: 10.26249/fk2/vagufz/u5447p
title: start_B_trajectories_part_016.csv

description: :unav
DOI: 10.26249/fk2/vagufz/bqdcws
title: start_B_trajectories_part_040.csv

description: :unav
DOI: 10.26249/fk2/vagufz/fmr4vy
title: start_B_trajectories_part_013.csv

description: :unav
DOI: 10.26249/fk2/vagufz/h2indi
title: start_B_trajectories_part_030.csv

description: :unav
DOI: 10.26249/fk2/vagufz/ivwic1
title: start_B_trajectories_part_027.csv

description: :unav
DOI: 10.26249/fk2/vagufz/jqwtvg
title: start_B_trajectories_part_033.csv

description: :unav
DOI: 10.26249/fk2/vagufz/rrrxi0
title: start_B_trajectories_part_022.csv

description: :unav
DOI: 10.26249/fk2/vagufz/497thc
title: start_B_trajectories_part_031.csv

description: :unav
DOI: 10.26249/fk2/vagufz/dmj5qb
title: start_B_trajectories_part_023.csv

description: :unav
DOI: 10.26249/fk2/vagufz/sa4ybn
title: start_B_trajectories_part_032.csv

description: :unav
DOI: 10.26249/fk2/vagufz/vqej0g
title: start_B_trajectories_part_026.csv

description: :unav
DOI: 10.26249/fk2/vagufz/zkbegl
title: start_B_trajectories_part_036.csv

description: :unav
DOI: 10.26249/fk2/vagufz/zwklj2
title: start_B_trajectories_part_037.csv

description: :unav
DOI: 10.26249/fk2/vagufz/3pbu7u
title: start_B_trajectories_part_038.csv

description: :unav
DOI: 10.26249/fk2/vagufz/gxwgpb
title: start_B_trajectories_part_025.csv

description: :unav
DOI: 10.26249/fk2/vagufz/qwwfyc
title: start_B_trajectories_part_029.csv

description: :unav
DOI: 10.26249/fk2/vagufz/secnwu
title: start_B_trajectories_part_039.csv

description: :unav
DOI: 10.26249/fk2/vagufz/tn9ywf
title: start_B_trajectories_part_021.csv

description: :unav
DOI: 10.26249/fk2/vagufz/uerrxr
title: start_B_trajectories_part_028.csv

description: :unav
DOI: 10.26249/fk2/vagufz/as7uka
title: start_B_trajectories_part_056.csv

description: :unav
DOI: 10.26249/fk2/vagufz/fsxpdf
title: start_B_trajectories_part_024.csv

description: :unav
DOI: 10.26249/fk2/vagufz/l2nchn
title: start_B_trajectories_part_034.csv

description: :unav
DOI: 10.26249/fk2/vagufz/qdfpkk
title: start_B_trajectories_part_035.csv

description: :unav
DOI: 10.26249/fk2/vagufz/wpv0kv
title: start_B_trajectories_part_057.csv

description: :unav
DOI: 10.26249/fk2/vagufz/0l7wgt
title: start_B_trajectories_part_055.csv

description: :unav
DOI: 10.26249/fk2/vagufz/3gdaei
title: start_B_trajectories_part_052.csv

description: :unav
DOI: 10.26249/fk2/vagufz/3jrxvy
title: start_B_trajectories_part_046.csv

description: :unav
DOI: 10.26249/fk2/vagufz/ai0jdq
title: start_B_trajectories_part_058.csv

description: :unav
DOI: 10.26249/fk2/vagufz/erst91
title: start_B_trajectories_part_053.csv

description: :unav
DOI: 10.26249/fk2/vagufz/jejgxd
title: start_B_trajectories_part_050.csv

description: :unav
DOI: 10.26249/fk2/vagufz/th0laq
title: start_B_trajectories_part_051.csv

description: :unav
DOI: 10.26249/fk2/vagufz/44cpug
title: start_B_trajectories_part_045.csv

description: :unav
DOI: 10.26249/fk2/vagufz/5gvizq
title: start_B_trajectories_part_054.csv

description: :unav
DOI: 10.26249/fk2/vagufz/arkzdx
title: start_B_trajectories_part_059.csv

description: :unav
DOI: 10.26249/fk2/vagufz/kp6qly
title: start_B_trajectories_part_049.csv

description: :unav
DOI: 10.26249/fk2/vagufz/rso5rf
title: start_B_trajectories_part_060.csv

description: :unav
DOI: 10.26249/fk2/vagufz/tjzily
title: start_B_trajectories_part_041.csv

description: :unav
DOI: 10.26249/fk2/vagufz/0bnpvl
title: start_B_trajectories_part_048.csv

description: :unav
DOI: 10.26249/fk2/vagufz/avcydo
title: start_B_trajectories_part_044.csv

description: :unav
DOI: 10.26249/fk2/vagufz/bnpiws
title: start_B_trajectories_part_087.csv

description: :unav
DOI: 10.26249/fk2/vagufz/dpnbly
title: start_B_trajectories_part_043.csv

description: :unav
DOI: 10.26249/fk2/vagufz/nsaj7z
title: start_B_trajectories_part_042.csv

description: :unav
DOI: 10.26249/fk2/vagufz/qhg2ue
title: start_B_trajectories_part_047.csv

description: :unav
DOI: 10.26249/fk2/vagufz/7kfwv5
title: start_B_trajectories_part_085.csv

description: :unav
DOI: 10.26249/fk2/vagufz/mqiv1o
title: start_B_trajectories_part_092.csv

description: :unav
DOI: 10.26249/fk2/vagufz/oy0bge
title: start_B_trajectories_part_086.csv

description: :unav
DOI: 10.26249/fk2/vagufz/uynpab
title: start_B_trajectories_part_083.csv

description: :unav
DOI: 10.26249/fk2/vagufz/vu5ho5
title: start_B_trajectories_part_071.csv

description: :unav
DOI: 10.26249/fk2/vagufz/2grdx8
title: start_B_trajectories_part_069.csv

description: :unav
DOI: 10.26249/fk2/vagufz/5eb8sa
title: start_B_trajectories_part_095.csv

description: :unav
DOI: 10.26249/fk2/vagufz/dpggmj
title: start_B_trajectories_part_061.csv

description: :unav
DOI: 10.26249/fk2/vagufz/fggkfm
title: start_B_trajectories_part_077.csv

description: :unav
DOI: 10.26249/fk2/vagufz/pbylsu
title: start_B_trajectories_part_062.csv

description: :unav
DOI: 10.26249/fk2/vagufz/tsbx9o
title: start_B_trajectories_part_078.csv

description: :unav
DOI: 10.26249/fk2/vagufz/4rocvr
title: start_B_trajectories_part_066.csv

description: :unav
DOI: 10.26249/fk2/vagufz/es6kjk
title: start_B_trajectories_part_065.csv

description: :unav
DOI: 10.26249/fk2/vagufz/j1xjjr
title: start_B_trajectories_part_076.csv

description: :unav
DOI: 10.26249/fk2/vagufz/nox1ig
title: start_B_trajectories_part_075.csv

description: :unav
DOI: 10.26249/fk2/vagufz/q9qzkw
title: start_B_trajectories_part_074.csv

description: :unav
DOI: 10.26249/fk2/vagufz/v1yh3p
title: start_B_trajectories_part_100.csv

description: :unav
DOI: 10.26249/fk2/vagufz/6nuqme
title: start_B_trajectories_part_099.csv

description: :unav
DOI: 10.26249/fk2/vagufz/g9qrvn
title: start_B_trajectories_part_089.csv

description: :unav
DOI: 10.26249/fk2/vagufz/o82ptk
title: start_B_trajectories_part_067.csv

description: :unav
DOI: 10.26249/fk2/vagufz/q08zdx
title: start_B_trajectories_part_068.csv

description: :unav
DOI: 10.26249/fk2/vagufz/qzzgkx
title: start_B_trajectories_part_073.csv

description: :unav
DOI: 10.26249/fk2/vagufz/rvvpuc
title: start_B_trajectories_part_070.csv

description: :unav
DOI: 10.26249/fk2/vagufz/8buynq
title: start_B_trajectories_part_084.csv

description: :unav
DOI: 10.26249/fk2/vagufz/gdgihr
title: start_B_trajectories_part_079.csv

description: :unav
DOI: 10.26249/fk2/vagufz/ic6sun
title: start_B_trajectories_part_093.csv

description: :unav
DOI: 10.26249/fk2/vagufz/qo3esx
title: start_B_trajectories_part_090.csv

description: :unav
DOI: 10.26249/fk2/vagufz/wwr1qo
title: start_B_trajectories_part_096.csv

description: :unav
DOI: 10.26249/fk2/vagufz/49gsbc
title: start_B_trajectories_part_098.csv

description: :unav
DOI: 10.26249/fk2/vagufz/7tv8kt
title: start_B_trajectories_part_088.csv

description: :unav
DOI: 10.26249/fk2/vagufz/mkya5i
title: start_B_trajectories_part_064.csv

description: :unav
DOI: 10.26249/fk2/vagufz/mqmrgs
title: start_B_trajectories_part_080.csv

description: :unav
DOI: 10.26249/fk2/vagufz/o7b1qv
title: start_B_trajectories_part_097.csv

description: :unav
DOI: 10.26249/fk2/vagufz/rzqyrd
title: start_B_trajectories_part_091.csv

description: :unav
DOI: 10.26249/fk2/vagufz/25eoja
title: start_B_trajectories_part_081.csv

description: :unav
DOI: 10.26249/fk2/vagufz/cqsuzb
title: start_B_trajectories_part_072.csv

description: :unav
DOI: 10.26249/fk2/vagufz/hasgi1
title: start_B_trajectories_part_137.csv

description: :unav
DOI: 10.26249/fk2/vagufz/i9riek
title: start_B_trajectories_part_082.csv

description: :unav
DOI: 10.26249/fk2/vagufz/l90h9t
title: start_B_trajectories_part_063.csv

description: :unav
DOI: 10.26249/fk2/vagufz/zs0i4n
title: start_B_trajectories_part_094.csv

description: :unav
DOI: 10.26249/fk2/vagufz/13q26w
title: start_B_trajectories_part_144.csv

description: :unav
DOI: 10.26249/fk2/vagufz/breyck
title: start_B_trajectories_part_146.csv

description: :unav
DOI: 10.26249/fk2/vagufz/fjuxyk
title: start_B_trajectories_part_135.csv

description: :unav
DOI: 10.26249/fk2/vagufz/rsjneb
title: start_B_trajectories_part_120.csv

description: :unav
DOI: 10.26249/fk2/vagufz/xhg1pc
title: start_B_trajectories_part_139.csv

description: :unav
DOI: 10.26249/fk2/vagufz/4xd5cr
title: start_B_trajectories_part_105.csv

description: :unav
DOI: 10.26249/fk2/vagufz/brglpc
title: start_B_trajectories_part_145.csv

description: :unav
DOI: 10.26249/fk2/vagufz/dncyd9
title: start_B_trajectories_part_121.csv

description: :unav
DOI: 10.26249/fk2/vagufz/iznwsz
title: start_B_trajectories_part_138.csv

description: :unav
DOI: 10.26249/fk2/vagufz/kdhz8i
title: start_B_trajectories_part_147.csv

description: :unav
DOI: 10.26249/fk2/vagufz/xuevyn
title: start_B_trajectories_part_131.csv

description: :unav
DOI: 10.26249/fk2/vagufz/hckamw
title: start_B_trajectories_part_113.csv

description: :unav
DOI: 10.26249/fk2/vagufz/hizsq3
title: start_B_trajectories_part_108.csv

description: :unav
DOI: 10.26249/fk2/vagufz/rgvjzn
title: start_B_trajectories_part_129.csv

description: :unav
DOI: 10.26249/fk2/vagufz/vgpwml
title: start_B_trajectories_part_140.csv

description: :unav